MedDataX Logo

Evaluation of the Animated Cartoon-aided Teaching of Intranasal Corticosteroid Allergic Rhinitis

NCT ID: NCT02571413

Last Updated: 2016-05-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-05-31

Study Completion Date

2010-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Correct methods and compliance of intranasal corticosteroid (INCS) is very important for the treatment of allergic rhinitis (AR). The animated cartoon-aided teaching of INCS administration was created to decrease workload of health care professionals. The aim of this study is to compare the achievement of the children with AR in using INCS between the group which were instructed by animated cartoon-aided teaching or oral presentation without demonstration.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Airway Inflammation in Children With Allergic Rhinitis and Intervention

NCT02352168

Allergic Rhinitis Inflammation Respiratory Tract Diseases +1 more
COMPLETED NA

As Needed Versus Regular Intranasal Corticosteroid in Children With Perennial Allergic Rhinitis

NCT05299086

Perennial Allergic Rhinitis Child, Only
COMPLETED PHASE3

Concomitant Intranasal Antihistamine and Corticosteroid in Stepwise Treatment Strategy for Allergic Rhinitis

NCT05708157

Allergic Rhinitis
UNKNOWN

Effectiveness of Oxymetazoline Added on Nasal Steroid in Rhinitis With Persistent Nasal Obstruction

NCT01847131

Nasal Obstruction Present Finding
COMPLETED PHASE4

Study on Association Between Treatment of Allergic Rhinitis and Cognitive Ability in Children

NCT03714945

Allergic Rhinitis
UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study was a prospective randomized control trial in children aged 5 - 16 years with moderate to severe intermittent or persistent AR who had never used INCS. The patients were randomly divided into 2 groups; 1) Teaching how to use INCS by oral presentation and 2) by animated cartoon-aided teaching. Successful achievements were recorded when the patients were able to use INCS (all five-point checklists) correctly. If they were unable to use the INCS correctly after the first teaching, the same instruction would be repeated and the second assessment would be performed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma Allergic Rhinitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

oral presentation

Scoring the correct use of INC before, immediate after and 3 months after oral presentation without demonstration "how to use INCS"

Group Type OTHER

score before teaching

Intervention Type OTHER

score the check-point of correct INCS usage before teaching

score immediately after teaching

Intervention Type OTHER

score the check-point of correct INCS usage immediately after teaching

score 3 months after teaching

Intervention Type OTHER

score the check-point of correct INCS usage 3 months after teaching

animated cartoon-aided VDO

Scoring the correct use of INC before, immediate after and 3 months after animated cartoon-aided teaching "how to use INCS"

Group Type OTHER

score before teaching

Intervention Type OTHER

score the check-point of correct INCS usage before teaching

score immediately after teaching

Intervention Type OTHER

score the check-point of correct INCS usage immediately after teaching

score 3 months after teaching

Intervention Type OTHER

score the check-point of correct INCS usage 3 months after teaching

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

score before teaching

score the check-point of correct INCS usage before teaching

Intervention Type OTHER

score immediately after teaching

score the check-point of correct INCS usage immediately after teaching

Intervention Type OTHER

score 3 months after teaching

score the check-point of correct INCS usage 3 months after teaching

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children with 5 - 16 year old
* children with allergic rhinitis

Exclusion Criteria

* history of intranasal corticosteroid use
* history of other underlying disease
Minimum Eligible Age

5 Years

Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Siriraj Hospital

OTHER

Sponsor Role collaborator

Nualanong Visitsunthorn

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nualanong Visitsunthorn

Somying Indradat

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nualanong Visitsunthorn, Prof

Role: PRINCIPAL_INVESTIGATOR

Mahidol University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Siriraj hospital, Mahidol University

Bangkok, Bangkok, Thailand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Thailand

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

[Si 9091/2552(EC2)]

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais
NCT01115595 COMPLETED PHASE4
Microbial Study of Sublingual Immunotherapy Spray in Patients With Allergic Rhinitis
NCT06741787 NOT_YET_RECRUITING
Budesonide Irrigation in Allergic Rhinitis
NCT06785662 NOT_YET_RECRUITING PHASE4
Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367)
NCT00442559 COMPLETED PHASE4
Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children
NCT00841256 COMPLETED PHASE3
Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in Thailand
NCT02000648 COMPLETED
Subjects With Clinical Diagnosis of Allergic Rhinitis Were Randomly Divided Into 2 Groups, With Patients in One Group Given One Treatment Session of Red Light Rhinophototherapy, Followed by Medical Treatment. Those in the Second Group Were Treated With Medical Treatment Only.
NCT03752645 COMPLETED NA
Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis
NCT00409409 COMPLETED PHASE3
The Development of Allergic Rhinitis in Children Previously Diagnosed as Nonallergic Rhinitis
NCT01068808 COMPLETED
Effect and Underlying Immunological Mechanisms of Sublingual Immunotherapy in Allergic Rhinitis
NCT03649139 COMPLETED PHASE3
Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age
NCT04957927 UNKNOWN PHASE4
Effect of Qi-tonifying Chinese Herbal Products for Treatment of Allergic Rhinitis
NCT01631032 COMPLETED PHASE3
A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) Rhinitis
NCT00730756 COMPLETED PHASE2
Sublingual Immunotherapy in Children With Allergic Rhinitis
NCT01506843 COMPLETED NA
Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients
NCT00578929 COMPLETED PHASE3
A Prospective, Randomized, Controlled Study Comparing the Efficacy of Intranasal Corticosteroids (INCS) Combined With Intranasal Antihistamines (INAH) and INCS Combined With Oral Antihistamines (OAH) in the Treatment of Moderate to Severe Allergic Rhinitis Symptoms
NCT07294326 NOT_YET_RECRUITING PHASE4
Allergic Inflammation in Rhinitis Patients Following Nasal Allergen Challenge
NCT01657097 COMPLETED PHASE4
Biomarker Screening for Immunotherapy Response Evaluation Using Microneedle Patch in Patients with Allergic Rhinitis
NCT05922176 RECRUITING
"Efficacy and Safety of Phlai Capsule Compared to Placebo as the Treatment in Allergic Rhinitis Patients"
NCT04182919 COMPLETED PHASE3
Nasal Budesonide Efficacy on Nasal FeNO in Children With Allergic Rhinitis
NCT02409563 COMPLETED PHASE4
Efficacy-safety Study of Sublingual Immunotherapy With Depigmented-polymerized Pollen Extracts to Treat Rhinoconjunctivitis
NCT00550875 COMPLETED PHASE2
A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR)
NCT02424539 COMPLETED PHASE4
Effect of High Intensity Interval Exercise Training in Patients With Allergic Rhinitis
NCT06543251 COMPLETED NA
Acute Effect of High Intensity Interval Exercise in Patients With Allergic Rhinitis
NCT05779046 COMPLETED NA
Singulair(R) In Asthma And Allergic Rhinitis (0476-383)
NCT00545844 COMPLETED PHASE4